Additionally, recent studies have reported that HE can modulate neural activity, such as increasing synaptic plasticity, reducing apoptosis, decreasing Aβ plaques, and inhibiting acetylcholinesterase (AChE) and BACE1 [27], supporting its therapeutic potential in the management of AD. This evidence concerns the gene ACHE and hereditary elliptocytosis.